TIAA Trust National Association Buys 1,764 Shares of Zoetis Inc. (NYSE:ZTS)

TIAA Trust National Association increased its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 1.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 123,829 shares of the company's stock after buying an additional 1,764 shares during the quarter. TIAA Trust National Association's holdings in Zoetis were worth $20,175,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Atlantic Edge Private Wealth Management LLC grew its stake in Zoetis by 482.8% during the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company's stock worth $28,000 after buying an additional 140 shares during the last quarter. Rakuten Securities Inc. raised its position in Zoetis by 5,533.3% in the 4th quarter. Rakuten Securities Inc. now owns 169 shares of the company's stock valued at $28,000 after purchasing an additional 166 shares during the last quarter. Dunhill Financial LLC boosted its stake in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company's stock worth $33,000 after purchasing an additional 75 shares in the last quarter. Asset Planning Inc bought a new stake in shares of Zoetis during the fourth quarter worth $58,000. Finally, Quarry LP increased its stake in shares of Zoetis by 45.9% in the third quarter. Quarry LP now owns 305 shares of the company's stock valued at $60,000 after buying an additional 96 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Zoetis news, Director Willie M. Reed sold 1,210 shares of Zoetis stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total transaction of $201,029.40. Following the completion of the transaction, the director now directly owns 11,245 shares of the company's stock, valued at $1,868,244.30. The trade was a 9.71 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Roxanne Lagano sold 326 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the transaction, the executive vice president now directly owns 15,781 shares in the company, valued at $2,682,770. The trade was a 2.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,862 shares of company stock valued at $312,254 over the last three months. Insiders own 0.16% of the company's stock.

Remove Ads

Zoetis Stock Down 1.2 %

NYSE:ZTS traded down $1.99 during trading hours on Friday, reaching $163.03. 1,550,283 shares of the stock were exchanged, compared to its average volume of 2,595,079. The stock has a market cap of $73.00 billion, a PE ratio of 29.80, a PEG ratio of 2.78 and a beta of 0.94. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.33. The firm has a 50 day moving average of $166.40 and a 200 day moving average of $174.55. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.75 and a quick ratio of 1.08.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.40 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.03. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.30 billion. On average, equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be paid a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.23%. Zoetis's dividend payout ratio is 36.56%.

Analyst Ratings Changes

ZTS has been the topic of a number of research analyst reports. Barclays increased their price objective on shares of Zoetis from $242.00 to $244.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Piper Sandler boosted their price objective on Zoetis from $200.00 to $205.00 and gave the stock an "overweight" rating in a report on Thursday, February 27th. Leerink Partners assumed coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an "outperform" rating and a $215.00 target price on the stock. UBS Group began coverage on Zoetis in a research note on Monday, December 9th. They set a "neutral" rating and a $196.00 price objective on the stock. Finally, StockNews.com upgraded Zoetis from a "hold" rating to a "buy" rating in a report on Friday, March 7th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $215.90.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.